- Home
- CERS vs AUDC Comparison
CERS vs AUDC Comparison
Compare CERS & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- AUDC
- Stock Information
- Founded
- CERS 1991
- AUDC 1992
- Country
- CERS United States
- AUDC Israel
- Employees
- CERS N/A
- AUDC N/A
- Industry
- CERS EDP Services
- AUDC Telecommunications Equipment
- Sector
- CERS Technology
- AUDC Utilities
- Exchange
- CERS Nasdaq
- AUDC Nasdaq
- Market Cap
- CERS 255.0M
- AUDC 282.4M
- IPO Year
- CERS 1997
- AUDC 1999
- Fundamental
- Price
- CERS $1.23
- AUDC $10.20
- Analyst Decision
- CERS Strong Buy
- AUDC Buy
- Analyst Count
- CERS 2
- AUDC 3
- Target Price
- CERS $3.50
- AUDC $11.67
- AVG Volume (30 Days)
- CERS 1.1M
- AUDC 87.5K
- Earning Date
- CERS 10-29-2025
- AUDC 11-05-2025
- Dividend Yield
- CERS N/A
- AUDC 3.92%
- EPS Growth
- CERS N/A
- AUDC 3.22
- EPS
- CERS N/A
- AUDC 0.46
- Revenue
- CERS $192,510,000.00
- AUDC $243,249,000.00
- Revenue This Year
- CERS $30.03
- AUDC $2.52
- Revenue Next Year
- CERS $9.37
- AUDC $1.74
- P/E Ratio
- CERS N/A
- AUDC $22.05
- Revenue Growth
- CERS 13.25
- AUDC N/A
- 52 Week Low
- CERS $1.12
- AUDC $7.70
- 52 Week High
- CERS $2.24
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- CERS 44.31
- AUDC 58.90
- Support Level
- CERS $1.17
- AUDC $9.56
- Resistance Level
- CERS $1.35
- AUDC $10.47
- Average True Range (ATR)
- CERS 0.07
- AUDC 0.26
- MACD
- CERS -0.00
- AUDC 0.11
- Stochastic Oscillator
- CERS 22.22
- AUDC 80.00
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.